Rolandic epilepsy-speech dyspraxia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:163721OMIM:245570G40.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rolandic epilepsy-speech dyspraxia syndrome (also known as RE-SD syndrome, or epilepsy with centrotemporal spikes and speech dyspraxia) is a rare genetic epilepsy syndrome that affects the brain, specifically the rolandic (centrotemporal) region responsible for motor control of the face, mouth, and speech. It is characterized by the combination of benign rolandic epilepsy (childhood epilepsy with centrotemporal spikes) and oromotor dysfunction manifesting as speech dyspraxia — a condition in which individuals have difficulty planning and coordinating the movements needed for speech. The syndrome has been linked to mutations in the GRIN2A gene, which encodes a subunit of the NMDA glutamate receptor, a critical component of excitatory neurotransmission in the brain. Key clinical features include focal seizures that typically occur during sleep, often involving twitching of the face or mouth, drooling, and difficulty speaking during the episode. Between seizures, affected individuals demonstrate oral and speech motor planning difficulties (dyspraxia), which can range from mild articulation problems to severe speech impairment. Some patients may also experience cognitive difficulties, including problems with reading and language development. The seizures associated with this syndrome typically begin in childhood and may remit by adolescence, similar to classic benign rolandic epilepsy, though the speech dyspraxia may persist. Treatment is primarily symptomatic. Antiepileptic medications such as carbamazepine, levetiracetam, or sulthiame may be used to control seizures. Speech and language therapy is an important component of management to address the oromotor dyspraxia. The prognosis for seizure control is generally favorable, as seizures often resolve with age, but the degree of speech and language recovery varies among individuals. Genetic counseling is recommended for affected families given the hereditary nature of the condition.

Clinical phenotype terms— hover any for plain English:

Speech apraxiaHP:0011098Bilateral tonic-clonic seizure with focal onsetHP:0007334EEG with focal sharp wavesHP:0011196EEG with generalized epileptiform dischargesHP:0011198Continuous spike and waves during slow sleepHP:0031491Incomprehensible speechHP:0002546Abnormally low-pitched voiceHP:0010300Abnormal prosodyHP:0031434
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rolandic epilepsy-speech dyspraxia syndrome.

View clinical trials →

No actively recruiting trials found for Rolandic epilepsy-speech dyspraxia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rolandic epilepsy-speech dyspraxia syndrome community →

No specialists are currently listed for Rolandic epilepsy-speech dyspraxia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rolandic epilepsy-speech dyspraxia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rolandic epilepsy-speech dyspraxia syndromeForum →

No community posts yet. Be the first to share your experience with Rolandic epilepsy-speech dyspraxia syndrome.

Start the conversation →

Latest news about Rolandic epilepsy-speech dyspraxia syndrome

No recent news articles for Rolandic epilepsy-speech dyspraxia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rolandic epilepsy-speech dyspraxia syndrome

What is Rolandic epilepsy-speech dyspraxia syndrome?

Rolandic epilepsy-speech dyspraxia syndrome (also known as RE-SD syndrome, or epilepsy with centrotemporal spikes and speech dyspraxia) is a rare genetic epilepsy syndrome that affects the brain, specifically the rolandic (centrotemporal) region responsible for motor control of the face, mouth, and speech. It is characterized by the combination of benign rolandic epilepsy (childhood epilepsy with centrotemporal spikes) and oromotor dysfunction manifesting as speech dyspraxia — a condition in which individuals have difficulty planning and coordinating the movements needed for speech. The syndro

How is Rolandic epilepsy-speech dyspraxia syndrome inherited?

Rolandic epilepsy-speech dyspraxia syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Rolandic epilepsy-speech dyspraxia syndrome typically begin?

Typical onset of Rolandic epilepsy-speech dyspraxia syndrome is childhood. Age of onset can vary across affected individuals.